Skip to main content
Skip to footer
EQL Pharma Investor Relations
Commercial website
Contact
Svenska
About Us
IR Contact
Vision
Mission
Business Concept
Business Model
Objectives
The Share
Share Information
Shareholders
Analyst
Reports
Annual Reports
Interim Reports
Financial Calendar
Corporate Governance
Management
Board
Auditor
Nomination Committee
General Meetings
Articles of Association
Media
Press Releases
Presentations
About Us
IR Contact
Vision
Mission
Business Concept
Business Model
Objectives
The Share
Share Information
Shareholders
Analyst
Reports
Annual Reports
Interim Reports
Financial Calendar
Corporate Governance
Management
Board
Auditor
Nomination Committee
General Meetings
Articles of Association
Media
Press Releases
Presentations
Interim Reports
2023/2024
Interim Report Q3 2023/2024
Interim Report Q2 2023/2024
Interim Report Q1 2023/2024
2022/2023
Year End Report 2022/2023
Interim Report Q3 2022/2023
Interim Report Q2 2022/2023
Interim Report Q1 2022/2023
2021/2022
Year End Report 2021/2022
Interim Report Q3 2021/2022
Interim Report Q2 2021/2022
Interim Report Q1 2021/2022
2020/2021
Year End Report 2020/2021
Interim Report Q3 2020/2021
Interim Report Q2 2020/2021
Interim Report Q1 2020/2021
2019/2020
Year End Report 2019/2020
Interim Report Q3 2019/2020
Interim Report Q2 2019/2020
Interim Report Q1 2019/2020
2018/2019
Year End Report 2018/2019
Interim Report Q3 2018/2019
Interim Report Q2 2018/2019
Interim Report Q1 2018/2019